Leidos Holdings Stock Price, News & Analysis

Leidos (LDOS) has welcomed nearly 900 summer interns from 290 colleges and universities across 34 states, the U.K., and Australia for summer 2025. The technology company, which operates in defense, homeland security, IT, intelligence, health, and energy sectors, has more than tripled its intern class size since 2016. The program boasts impressive success metrics with 90% of interns receiving job offers or returning for additional internships. In 2025, over 450 recent graduates have already accepted full-time positions at Leidos. The intern class represents 38 different college majors, demonstrating the company's commitment to diverse talent acquisition. CEO Tom Bell emphasized the internship program's importance as a crucial investment in the company's future, highlighting how interns work alongside existing teams to gain industry experience while bringing fresh perspectives.

Leidos (LDOS) is developing an innovative magnetic navigation (MagNav) technology to counter GPS jamming vulnerabilities in military applications. The project, under a Defense Innovation Unit contract, leverages quantum sensing technology using nitrogen in diamonds to measure Earth's magnetic field variations. Led by Aaron Canciani, the technology utilizes quantum magnetometers developed by Frequency Electronics in collaboration with MIT Lincoln Lab. The quantum-based approach offers superior accuracy and stability compared to traditional magnetometers, as measurements are based on fundamental physics constants rather than relative measurements that can drift. This advancement could significantly enhance military navigation capabilities by providing a jam-proof alternative to GPS.

Leidos (NYSE:LDOS) has acquired Kudu Dynamics for $300 million in an all-cash transaction, marking its first acquisition in 2.5 years. The deal, which closed on May 23, 2025, strengthens Leidos' AI-enabled cyber capabilities for defense, intelligence, and homeland security customers. Kudu Dynamics, founded in 2013, specializes in automated targeting, hardware reverse engineering, and non-kinetic effects for the Department of Defense. The acquisition aligns with Leidos' NorthStar 2030 strategy and aims to enhance its offensive cyber technology capabilities, particularly in electromagnetic spectrum operations and vulnerability research. The deal represents a strategic move to bolster Leidos' position in the cyber warfighting domain.

Leidos (NYSE:LDOS) has signed a memorandum of understanding with Saudi Arabia's National Security Services Company (SAFE) to collaborate on security screening technology for airports and ports of entry across Saudi Arabia. The agreement, signed on May 13, 2025, focuses on modernizing Saudi Arabia's security infrastructure through Leidos' screening solutions, including people and baggage scanners, explosive detection devices, and cargo screening systems.

The partnership will combine Leidos' technology with localized training and services to enhance threat detection capabilities. The agreement was formalized during the U.S-Saudi Investment Forum, coinciding with the U.S. President's visit to Saudi Arabia.

Leidos (NYSE: LDOS) reported strong Q1 2025 financial results with revenues of $4.2 billion, up 7% year-over-year. The company achieved net income of $365 million ($2.77 per diluted share) and Adjusted EBITDA of $601 million (14.2% margin). Non-GAAP EPS grew 30% to $2.97. The company generated $58 million in operating cash flow and $36 million in free cash flow. Notable developments include a $500 million accelerated share repurchase, issuance of $1 billion in senior notes, and a pending $300 million acquisition of a cyber platforms company. Leidos secured several major contracts, including a $205 million DTRA task order and maintained a backlog of $46.3 billion. The company reaffirmed its FY2025 guidance with expected revenues of $16.90-$17.30 billion.

Leidos (LDOS) has secured a $205 million contract to modernize and operate IT systems for the Defense Threat Reduction Agency (DTRA). The five-year Integrated Information Technology Support Services (I3TS) contract focuses on implementing Zero Trust cybersecurity and leveraging artificial intelligence to enhance operational efficiency. Leidos will develop a resilient, secure hybrid cloud architecture and implement data-driven operations to modernize DTRA's enterprise.

This contract expands Leidos' presence within the Department of Defense's "Fourth Estate" and builds upon their existing relationship with DTRA. The project aims to help DTRA deter, prevent, and counter emerging global threats through enhanced IT capabilities and security measures.

Leidos Holdings (NYSE: LDOS) has announced a quarterly cash dividend of $0.40 per share for its common stock shareholders. The dividend will be paid on June 30, 2025, to stockholders who are on record as of the close of business on June 16, 2025.

Leidos (NYSE: LDOS) and Protect AI have announced a strategic collaboration to enhance security for AI systems used across U.S. government agencies. The partnership combines Leidos' secure digital transformation expertise with Protect AI's platform to provide comprehensive protection against AI threats, particularly focusing on next-generation agentic AI models.

The collaboration aims to deliver full lifecycle security capabilities across the AI supply chain for national security, defense, intelligence, healthcare, and civil agencies. Protect AI's platform includes three key tools: Guardian for zero-trust security scanning, Recon for automated red-teaming of generative AI, and Layer for LLM runtime security.

This initiative addresses critical concerns about agentic AI models, which can make autonomous decisions without human intervention, potentially posing risks to government agencies responsible for protecting national security and infrastructure. The partnership focuses on ensuring trust, compliance, and security in government AI systems while enabling secure AI innovation at scale.

Leidos (NYSE: LDOS) has announced a $10 million investment in a five-year collaboration with the University of Pittsburgh's Computational Pathology and AI Center of Excellence (CPACE). The partnership aims to accelerate the development of AI-powered tools for disease detection and management, particularly focusing on heart disease and cancer.

The collaboration will establish a world-class research hub through CPACE's Digital Pathology Research Center, develop digital healthcare solutions, and accelerate global impact through AI-powered pathology solutions across public and private healthcare sectors. Key objectives include exploring new imaging methods, advanced scanning technologies, and improved medical image analysis techniques.

The initiative also emphasizes workforce development through educational programs, industry-focused best practices, annual symposiums, and internship opportunities. Leidos brings over 25 years of experience operating the National Cancer Institute's Frederick National Laboratory for Cancer Research and two decades of AI application expertise in healthcare, national security, and energy sectors.